$7,984.90 Million NGS-Based RNA-Seq Market is estimated to reach at a CAGR of 19.3% till 2027 led by Pacific Biosciences of California, Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, BGI, Oxford Nanopore Technologies

NGS based RNA seq is done without a reference sequence for the strand-specific libraries that are being profiled for the rare and novel therapeutics. It is highly revolutionized study of the transcriptome which is highly sensitive and accurate for the measurement of the expression all over the transcriptome. The NGs based RNA seq provides researchers with visibility for previously undetected changes occurring in disease states, in response to therapeutics caused by different environmental conditions. In addition, this technique enables researchers to detect the known and unknown features in single assay. The report would be of an interest to various stakeholders operating in the NGS based RNA seq market. These stakeholders include manufacturing companies, dealer companies, supplier companies, wholesalers, hospitals, research centers and others.

The objective of the study is to describe, define, and forecast the NGS based RNA seq market by product & services, technology, application, end user and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPBT00002556

Major Players Operating in the NGS-based RNA-seq Market-
1. Illumina, Inc.
2. Thermo Fisher Scientific Inc.
3. Pacific Biosciences of California, Inc.
4. Qaigen
5. F. Hoffmann-La Roche AG
6. Agilent Technologies, Inc.
7. BGI
8. Oxford Nanopore Technologies
9. Perkinelmer, Inc.
10. Eurofins Scientific

According to a new market research study titled ‘NGS-Based RNA-Seq Market to 2027 – Global Analysis and Forecasts by Product & Services, Technology, Application and End User, the global NGS-based RNA-seq market was valued at US$ 1,240.87 Mn in 2017 and is estimated to reach US$ 7,984.90 Mn by 2027. The market is estimated to grow with a CAGR of 19.3% from 2018-2027.The report highlights the trends prevalent in the global NGS-based RNA-seq market and the factors driving the market along with those that act as deterrents to its growth.

Global NGS-based RNA-seq market is expected to grow in the coming years, owing to the factors such as, reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer. However, the risks related to genetic data and high cost of NGS instruments is act as a restraint for this market. On the other hand, barcode scanning for long reads sequences likely to add novel opportunities for NGS-based RNA-seq market, in the coming years.

Browse Complete Report at https://www.theinsightpartners.com/reports/ngs-based-rna-seq-market

The report segments the global NGS-based RNA-seq market as follows:

Global NGS-Based RNA-Seq Market – By Product & Services
• Sample Preparation
• Method
• Manual Method
• Automated Method
• Workflow Step
• Library Preparation & Target Enrichment
• Fragmentation, End Repair & Size Selection
• Quality Control
• Sequencing Services
• Sequencing Platform & Consumables
• Data Analysis, Storage & Management

Global NGS-Based RNA-Seq Market – By Technology
• Sequencing By Synthesis
• Nanopore Sequencing
• Ion Semiconductor Sequencing
• Single-Molecule Real-Time (SMRT) Sequencing

Global NGS-Based RNA-Seq Market – By Application
• Diagnostics
• Drug Discovery
• Precision Medicine
• Others

Global NGS-Based RNA-Seq Market – By End User
• Hospitals & Clinics
• Research Centers and Academic & Government Institutes
• Biotechnology & Pharmaceutical Companies
• Others

Global NGS-Based RNA-Seq Market – By Geography
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Asia Pacific (APAC)
• Japan
• China
• India
• Middle East & Africa (MEA)
• U.A.E
• Saudi Arabia
• South Africa
• South and Central America (SCAM)
• Brazil

Buy this Report now at https://www.theinsightpartners.com/buy/TIPBT00002556

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Healthcare IT, Biotechnology and Medical Device industries.

Contact us -
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com

This release was published on openPR.